186 results
Page 9 of 10
6-K
EX-99.1
8ae kl8m6i
26 Aug 14
RepliCel Announces 2014 Second Quarter Financial Results
12:00am
6-K
EX-99.1
04ehdkr4
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
b7ru2r fnqh8zodx
17 Jul 14
RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
12:00am
6-K
EX-99.1
9xql22c
23 Jun 14
RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
12:00am
6-K
EX-99.1
otfpbx60hn36r0f1mas8
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am
6-K
EX-99.1
z106mfde2n7258l3v
6 Jun 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.1
4yrkmdkxc121
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.2
by2pcuzfm9
29 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
w2174eyjn0ea 550
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
ltwwtunwhgnkphhze op
22 May 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99.2
x49q50rih3n0mb91ltx1
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
cw7 rqw2kg3zl5y
18 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
042md2
18 Mar 14
RepliCel Reports 2013 Annual Financial Results
12:00am
6-K
EX-99.1
tbd42vncxp63l4ogbu
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
6-K
EX-99.1
5uo2c0tyzv uu18yf
27 Feb 14
Replicel Life Sciences Inc. Form 6-K
12:00am
6-K
EX-99
1t077
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
f5ij3vcn7
20 Nov 13
Current report (foreign)
12:00am
6-K
EX-99.2
cb9zu
28 Aug 13
Current report (foreign)
12:00am
6-K
EX-99.1
j0y5vr9 v9jijh
28 Aug 13
Current report (foreign)
12:00am